Perigon Wealth Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Perigon Wealth Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,830	Closed	-$268K	–	850
2023 Q3	$268K	Hold	1,830	–	–	0.01%	627
2023 Q2	$280K	Hold	1,830	–	–	0.01%	632
2023 Q1	$284K	Sell	1,830 -600	-25%	-$94.2K	0.02%	554
2022 Q4	$375K	Buy	+2,430	New	+$359K	0.02%	460
2018 Q2	–	Sell	-400	Closed	-$53K	–	361
2018 Q1	$53K	Buy	+400	New	+$54.6K	0.02%	300
2017 Q4	–	Sell	-400	Closed	-$50K	–	630
2017 Q3	$50K	Hold	400	–	–	0.02%	336
2017 Q2	$46K	Hold	400	–	–	0.01%	385
2017 Q1	$42K	Hold	400	–	–	0.01%	408
2016 Q4	$42K	Hold	400	–	–	0.01%	378
2016 Q3	$40K	Buy	+400	New	+$39.2K	0.01%	334

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Perigon Wealth Management's FBT Position: Q4 2023 in Review

Perigon Wealth Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2023, closing a stake of 1,830 shares — an estimated $268K sold.

Perigon Wealth Management first reported a position in FBT in Q3 2016 and held it in 10 quarters. The position peaked at $375K in Q4 2022. 257 funds tracked by Wall St. Rank hold FBT as of Q4 2023.

Perigon Wealth Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2023 after selling out during the quarter.
Perigon Wealth Management sold 1,830 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2023, an estimated $268K.
Perigon Wealth Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q3 2016 and held it in 10 quarters.
Perigon Wealth Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $375K in Q4 2022.
257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2023.

Based on Perigon Wealth Management's 13F filing for Q4 2023, filed 29 Jan 2024.